Yu J, Ren L, Wu T, Hua L, Wang D, Wang Y
J Neurooncol. 2025; .
PMID: 40019713
DOI: 10.1007/s11060-025-04966-6.
Berfelde J, Hildebrand L, Kuhlmann L, Fietkau R, Distel L
Int J Mol Sci. 2024; 25(4).
PMID: 38396787
PMC: 10889347.
DOI: 10.3390/ijms25042110.
Klieber N, Hildebrand L, Faulhaber E, Symank J, Hack N, Hartl A
Cells. 2024; 13(4.
PMID: 38391917
PMC: 10887161.
DOI: 10.3390/cells13040304.
Dueva R, Krieger L, Li F, Luo D, Xiao H, Stuschke M
Int J Mol Sci. 2023; 24(19).
PMID: 37834389
PMC: 10573259.
DOI: 10.3390/ijms241914941.
Bertolet A, Chamseddine I, Paganetti H, Schuemann J
Front Oncol. 2023; 13:1196502.
PMID: 37397382
PMC: 10313124.
DOI: 10.3389/fonc.2023.1196502.
Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11.
Tallman M, Zalenski A, Stabl I, Schrock M, Kollin L, de Jong E
Cancers (Basel). 2023; 15(12).
PMID: 37370783
PMC: 10296095.
DOI: 10.3390/cancers15123173.
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
Scheper J, Hildebrand L, Faulhaber E, Deloch L, Gaipl U, Symank J
Strahlenther Onkol. 2022; 199(12):1128-1139.
PMID: 36229655
PMC: 10673781.
DOI: 10.1007/s00066-022-02009-x.
Biological effectiveness and relative biological effectiveness of ion beams for in-vitro cell irradiation.
Li H
Cancer Sci. 2022; 113(8):2807-2813.
PMID: 35642350
PMC: 9357665.
DOI: 10.1111/cas.15446.
Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors.
Peinado-Serrano J, Carnero A
Cancers (Basel). 2022; 14(9).
PMID: 35565331
PMC: 9101029.
DOI: 10.3390/cancers14092202.
Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation.
Jost T, Heinzerling L, Fietkau R, Hecht M, Distel L
Front Oncol. 2021; 11:740002.
PMID: 34722291
PMC: 8548830.
DOI: 10.3389/fonc.2021.740002.
In silico simulation of the effect of hypoxia on MCF-7 cell cycle kinetics under fractionated radiotherapy.
Remigio A
J Biol Phys. 2021; 47(3):301-321.
PMID: 34533654
PMC: 8452821.
DOI: 10.1007/s10867-021-09580-x.
Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells.
Faulhaber E, Jost T, Symank J, Scheper J, Burkel F, Fietkau R
Genes (Basel). 2021; 12(6).
PMID: 34204447
PMC: 8235750.
DOI: 10.3390/genes12060925.
Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential.
Burkel F, Jost T, Hecht M, Heinzerling L, Fietkau R, Distel L
Int J Mol Sci. 2020; 21(23).
PMID: 33297429
PMC: 7730287.
DOI: 10.3390/ijms21239321.
Impact of hypoxia on the double-strand break repair after photon and carbon ion irradiation of radioresistant HNSCC cells.
Wozny A, Alphonse G, Cassard A, Malesys C, Louati S, Beuve M
Sci Rep. 2020; 10(1):21357.
PMID: 33288855
PMC: 7721800.
DOI: 10.1038/s41598-020-78354-7.
Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency.
Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H
Sci Rep. 2020; 10(1):20873.
PMID: 33257719
PMC: 7705701.
DOI: 10.1038/s41598-020-77969-0.
Combination Strategies to Improve Targeted Radionuclide Therapy.
Chan T, ONeill E, Habjan C, Cornelissen B
J Nucl Med. 2020; 61(11):1544-1552.
PMID: 33037092
PMC: 8679619.
DOI: 10.2967/jnumed.120.248062.
Mitotic cells can repair DNA double-strand breaks via a homology-directed pathway.
Sakamoto Y, Kokuta T, Teshigahara A, Iijima K, Kitao H, Takata M
J Radiat Res. 2020; 62(1):25-33.
PMID: 33009557
PMC: 7779344.
DOI: 10.1093/jrr/rraa095.
Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB signaling.
You Y, Wang Q, Li H, Ma Y, Deng Y, Ye Z
Onco Targets Ther. 2019; 12:4323-4330.
PMID: 31239706
PMC: 6556542.
DOI: 10.2147/OTT.S202516.
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.
Marampon F, Ciccarelli C, Zani B
Int J Mol Sci. 2019; 20(10).
PMID: 31126017
PMC: 6567863.
DOI: 10.3390/ijms20102530.
Moscatilin Inhibits Growth of Human Esophageal Cancer Xenograft and Sensitizes Cancer Cells to Radiotherapy.
Chen W, Chen C, Chi C, Li L, Lin C, Shieh H
J Clin Med. 2019; 8(2).
PMID: 30764514
PMC: 6406854.
DOI: 10.3390/jcm8020187.
